With Personalized Pricing, Disclosure Is a Start, But Not a Finish Line
TINA.org and other consumer advocates file comment with FTC.
October 2017: A California appellate court reversed the trial court decision finding that plaintiffs did present enough evidence to support their claims, and directed the trial court to enter a judgment in favor of plaintiffs. (Rosendez et al v. Green Pharmaceuticals, Case No. D071073, California Court of Appeals – Fourth District)
2014: After plaintiffs presented evidence at trial, the judge assigned to the case concluded that plaintiffs did not present enough evidence to support their claims and entered a judgment in favor of Green Pharmaceuticals.
2011: A class-action lawsuit was filed against Green Pharmaceuticals for allegedly deceptively marketing SnoreStop as a pill that stops snoring when, according to plaintiffs, it has no impact on snoring. (Rosendez et al v. Green Pharmaceuticals, Case No. CIVDS1108022, California Superior Court – San Bernardino)
TINA.org and other consumer advocates file comment with FTC.
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Marketing and reality are not in sync.
New study opens the floodgates to class-action litigation.
Agency alleges MLM misled recruits about earnings, pressured distributors to buy products and encouraged fake retail sales.